Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone.

Michaelides, Michael; Levinstein, Marjorie; De Oliveira, Paulo; Casajuana-Martin, Nil; Quiroz, Cesar; Budinich, Reece; Rais, Rana; Rea, William; Ventriglia, Emilya; Llopart, Natàlia; Casadó-Anguera, Verònica; Moreno, Estefanía; Walther, Donna; Glatfelter, Grant; Weinshenker, David; Zarate, Carlos; Casado, Vicent; Baumann, Michael; Pardo, Leonardo; Ferre, Sergi.

Affiliation

Michaelides M; NIH.
Levinstein M; National Institute on Drug Abuse.
De Oliveira P; National Institute on Drug Abuse.
Casajuana-Martin N; Universitat Autònoma Barcelona.
Quiroz C; National Institute on Drug Abuse.
Budinich R; National Institute on Drug Abuse.
Rais R; Johns Hopkins School of Medicine.
Rea W; National Institute on Drug Abuse.
Ventriglia E; National Institute on Drug Abuse.
Llopart N; Universitat de Barcelona.
Casadó-Anguera V; Universitat de Barcelona.
Moreno E; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona.
Walther D; National Institute on Drug Abuse.
Glatfelter G; National Institute on Drug Abuse.
Zarate C; NIMH.
Casado V; University of Barcelona.
Baumann M; National Institute on Drug Abuse.
Pardo L; Universitat Autonoma de Barcelona.
Ferre S; National Institute on Drug Abuse.